PolyPeptide Group's earnings have been declining at an average annual rate of -44.5%, while the Life Sciences industry saw earnings declining at 0.4% annually. Revenues have been growing at an average rate of 9.8% per year. PolyPeptide Group's return on equity is 4.1%, and it has net margins of 3.1%.
Key information
-44.54%
Earnings growth rate
-45.15%
EPS growth rate
Life Sciences Industry Growth
36.86%
Revenue growth rate
9.79%
Return on equity
4.11%
Net Margin
3.15%
Next Earnings Update
09 Mar 2027
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How PolyPeptide Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BATS-CHIXE:PPGNZ Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
30 Jun 26
459
14
69
3
31 Mar 26
424
-3
62
3
31 Dec 25
389
-21
56
2
30 Sep 25
379
-28
52
2
30 Jun 25
369
-35
49
2
31 Mar 25
353
-27
46
1
31 Dec 24
337
-20
44
1
30 Sep 24
330
-24
44
1
30 Jun 24
324
-29
43
1
31 Mar 24
322
-40
42
1
31 Dec 23
320
-51
42
1
30 Sep 23
300
-44
41
1
30 Jun 23
279
-37
40
1
31 Mar 23
280
-14
40
1
31 Dec 22
281
8
41
1
30 Sep 22
281
20
40
1
30 Jun 22
281
33
40
1
31 Mar 22
281
40
36
1
31 Dec 21
282
47
32
1
30 Sep 21
277
48
31
1
30 Jun 21
271
48
29
1
31 Mar 21
248
40
28
1
31 Dec 20
224
31
28
1
31 Dec 19
203
26
25
1
31 Dec 18
181
24
24
12
Quality Earnings: PPGNZ has high quality earnings.
Growing Profit Margin: PPGNZ became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PPGNZ's earnings have declined by 44.5% per year over the past 5 years.
Accelerating Growth: PPGNZ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PPGNZ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (5.4%).
Return on Equity
High ROE: PPGNZ's Return on Equity (4.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/08/17 13:34
End of Day Share Price
2026/08/14 00:00
Earnings
2026/06/30
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PolyPeptide Group AG is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.